-+ 0.00%
-+ 0.00%
-+ 0.00%

LYELL IMMUNOPHARMA - ADDITIONAL PHASE 1 DATA AND FDA MEETING EXPECTED IN SECOND HALF OF 2026

Reuters·06/08/2026 10:00:00

Please log in to view news